Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia.
Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic variants associated with response to dutasteride trea...
Main Authors: | Arang Rhie, Ho-Young Son, Soo Jung Kwak, Seungbok Lee, Dong Young Kim, Bark-Lynn Lew, Woo-Young Sim, Jeong-Sun Seo, Ohsang Kwon, Jong-Il Kim, Seong Jin Jo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222533 |
Similar Items
-
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis
by: Solam Lee, et al.
Published: (2018-09-01) -
The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
by: Zhou Z, et al.
Published: (2019-02-01) -
Management Of Androgenetic Alopecia
by: Sharma V.K, et al.
Published: (2000-01-01) -
Androgenetic alopecia - Current status
by: Thomas Jayakar
Published: (2005-01-01) -
PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN
by: Riezky Januar Pramitha, et al.
Published: (2013-03-01)